Isolated elevated serum transaminases leading to the diagnosis of asymptomatic Pompe disease

European Journal of Pediatrics

Volumn 166, Issue 8, 2007, Pages 871-874

  Hoeksma, Marieke ^a   Boon, Maartje ^b   Niezen Koning, Klary E ^b   Van Overbeek Van Gils, Lidy ^c   Van Spronsen, Francjan J ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c Scheper Ziekenhuis   (Netherlands)

Author keywords

Acid alpha glucosidase; Asymptomatic patients; Glycogen storage disease type II; Pompe disease

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATINE KINASE; GLUCAN 1,4 ALPHA GLUCOSIDASE; GLYCOGEN;

AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BLOOD ANALYSIS; CASE REPORT; CREATINE KINASE BLOOD LEVEL; DNA DETERMINATION; DOPPLER FLOWMETRY; ENZYME REPLACEMENT; GLYCOGEN STORAGE DISEASE TYPE 2; HUMAN; INFANT; LIVER DISEASE; MALE; MOUTH INFECTION; MUSCLE BIOPSY; NEUROLOGIC EXAMINATION; NEWBORN JAUNDICE; PHOTOTHERAPY; PRIORITY JOURNAL; PROGNOSIS;

ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; CREATINE KINASE; GLUCAN 1,4-ALPHA-GLUCOSIDASE; GLYCOGEN STORAGE DISEASE TYPE II; HUMANS; INFANT; MALE;

EID: 34250860772     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-006-0315-9     Document Type: Article

References (22)

1. Ausems MGEM, Verbiest J, Hermans MMP, Kroos MA, Beemer FA, Wokke JHJ, Sandkuijl LA, Reuser AJJ, van der Ploeg AT (1999) Frequency of glycogen storage disease type II in The Netherlands: implications for diagnosis and genetic counseling. Eur J Hum Genet 7:713-716
2. Ausems MGEM, Lochman P, van Diggelen OP, Ploos van Amstel HK, Reuser AJJ, Wokke JHJ (1999) A diagnostic protocol for adult-onset glycogen storage disease type II. Neurology 52:851-853
3. Ausems MGEM, ten Berg K, Beemer FA, Wokke JHJ (2000) Phenotypic expression of late-onset glycogen storage disease type II: identification of asymptomatic adults through family studies and review of reported families. Neuromuscul Disord 10:467-471
4. Chamoles NA, Niizawa G, Blanco M, Gaggioli D, Casentini C (2004) Glycogen storage disease type II: enzymatic screening in dried blood spots on filter paper. Clin Chim Acta 347:97-102
5. Danon MJ, DiMauro S, Archer FL, Miranda AF (1986) Juvenile-onset acid maltase deficiency with unusual familial features. Neurology 36:818-822
6. Felice KJ, Alessi AG, Grunnet ML (1995) Clinical variability in adult-onset acid maltase deficiency: report of affected sibs and review of the literature. Medicine 74:131-135
7. Hagemans MLC, Winkel LPF, van Doorn PA, Hop WJC, Loonen MCB, Reuser AJJ, van der Ploeg AT (2005) Clinical manifestations and natural course of late-onset Pompe's disease in 54 Dutch patients. Brain 128:671-677
8. Hirschhorn R, Reuser AJJ (2001) Glycogen storage disease type II: acid alpha-glucosidase (acid maltase) deficiency. In: Scriver CR, Beaudet A, Sly WS, Valle D (eds) The metabolic and molecular base of inherited disease, 8th edn. McGraw-Hill, New York, pp 3389-3420
9. Huie ML, Chen AS, Tsujino S, Shanske S, DiMauro S, Engel AG, Hirschhorn R (1994) Aberrant splicing in adult onset glycogen storage disease type II (GSDII): molecular identification of an IVS1(-13T→G) mutation in a majority of patients and a novel IVS10(+1GT→CT) mutation. Hum Mol Genet 3:2231-2236
10. Klinge L, Straub V, Neudorf U, Schaper J, Bosbach T, Gorlinger K, Wallot M, Richards S, Voit T (2005) Safety and efficacy of recombinant acid alpha-glucosidase (rhGAA) in patients with classical infantile Pompe disease: results of a phase II clinical trial. Neuromuscul Disord 15:24-31
11. Kroos MA, Van der Kraan M, Van Diggelen OP, Kleijer WJ, Reuser AJ, Van den Boogaard MJ, Ausems MGEM, Ploos van Amstel HK, Poenaru L, Nicolino M, Wevers R (1995) Glycogen storage disease type II: frequency of three common mutant alleles and their associated clinical phenotypes studied in 121 patients. J Med Genet 32:836-837
12. Morse RP, Rosman NP (1992) Diagnosis of occult muscular dystrophy:importance of the "chance" finding of elevated serum aminotransferase activities. J Pediatr 122:254-256
13. Nathwani RA, Pais S, Reynolds TB, Kaplowitz N (2005) Serum alanine aminotransferase in skeletal muscle diseases. Hepatology 41:380-382
14. Pavic M, Petiot P, Streichenberger N, Dupond JL, Drouet A, Flocard F, Bouhou F, Colin J, Bielefeld YP, Gouttard M, Maire I, Pellat J, Vital Durand D, Rousset H (2003) Analysis of 12 cases of Mc Ardle's disease diagnosed after 30 years. Rev Med Interne 24:716-720
15. Schwarz KB, Burris GC, deMello DE, Hyams JS, Biller JA, Maksimak MG, Winter HS, Grand RJ (1984) Prolonged elevation of transaminase concentration in children with unsuspected myopathy. Am J Dis Child 138:1121-1124
16. Umapathysivam K, Whittle AM, Ranieri E, Bindloss C, Ravenscroft EM, van Diggelen OP, Hopwood JJ, Meikle PJ (2000) Determination of acid alpha-glucosidase protein: evaluation as a screening marker for Pompe disease and other lysosomal storage disorders. Clin Chem 46:1318-1325
17. Umapathysivam K, Hopwood JJ, Meikle PJ (2001) Determination of acid alpha-glucosidase activity in blood spots as a diagnostic test for Pompe disease. Clin Chem 47:1378-1383
18. Van den Hout HMP, Hop W, van Diggelen OP, Smeitink JAM, Smit GPA, Poll-The BTT, Bakker HD, Loonen MCB, de Klerk JBC, Reuser AJJ, van der Ploeg AT (2003) The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature. Pediatrics 112:332-340
19. Van den Hout JMP, Kamphoven JH, Winkel LP, Arts WF, De Klerk JB, Loonen MC, Vulto AG, Cromme-Dijkhuis A, Weisglas-Kuperus N, Hop W, Van Hirtum H, Van Diggelen OP, Boer M, Kroos MA, Van Doorn PA, Van der Voort E, Sibbles B, Van Corven EJ, Brakenhoff JP, Van Hove J, Smeitink JA, de Jong G, Reuser AJ, Van der Ploeg AT (2004) Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk. Pediatrics 113:e448-e457
20. Winkel LPF, van den Hout JM, Kamphoven JH, Disseldorp JA, Remmerswaal M, Arts WF, Loonen MC, Vulto AG, van Doorn PA, de Jong G, Hop W, Smit GP, Shapira SK, Boer MA, van Diggelen OP, Reuser AJ, van der Ploeg AT (2004) Enzyme replacement therapy in late-onset Pompe's disease: a three year follow-up. Ann Neurol 55:495-502
21. Winkel LPF, Hagemans MLC, van Doorn PA, Loonen MCB, Hop WJC, Reuser AJJ, van der Ploeg AT (2005) The natural course of Pompe's disease; a review of 225 published cases. J Neurol 252:875-884
22. Wokke JHJ, Ausems MGEM, van den Boogaard MJH, Ippel EF, van Diggelen O, Kroos MA, Boer M, Jennekens FGI, Reuser AJJ, Ploos van Amstel HK (1995) Genotype-Phenotype correlation in adult-onset acid maltase deficiency. Ann Neurol 38:450-545